Projects per year
Fingerprint Dive into the research topics where Abdullah Kutlar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
Sickle Cell Anemia
Medicine & Life Sciences
Thalassemia
Medicine & Life Sciences
Globins
Medicine & Life Sciences
Abnormal Hemoglobins
Chemical Compounds
Fetal Hemoglobin
Medicine & Life Sciences
Hemoglobins
Medicine & Life Sciences
Hydroxyurea
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2001 2018
The Role of Endothelin-1 in Sickle Cell Disease
Meiler, S., Pollock, D. & Kutlar, A.
8/15/13 → 5/31/18
Project: Research project
Sickle Cell Anemia
Endothelin-1
Translational Medical Research
Research
Pain
NCMHD Southeastern Exploratory Sickle Cell Center of Excellence
Adamkiewicz, T., Gibson, R. W., Ikuta, T., Kutlar, A., Gibson, R. W., Gibson, R. W. & Tuan Lo, D.
5/28/09 → 12/31/15
Project: Research project
Sickle Cell Anemia
Hydroxyurea
gamma-Globins
Globins
Opioid Analgesics
Factor V
Sickle Cell Anemia
Genetic Polymorphisms
Mutation
Stroke
Research Output 1979 2019
5
Citations
(Scopus)
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis
Kutlar, A., Kanter, J., Liles, D. K., Alvarez, O. A., Cançado, R. D., Friedrisch, J. R., Knight-Madden, J. M., Bruederle, A., Shi, M., Zhu, Z. & Ataga, K. I., Jan 1 2019, In : American Journal of Hematology. 94, 1, p. 55-61 7 p.Research output: Contribution to journal › Article
Sickle Cell Anemia
Pain
Placebos
Hydroxyurea
P-Selectin
6
Citations
(Scopus)
MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease
Li, B., Zhu, X., Ward, C. M., Starlard-Davenport, A., Takezaki, M., Berry, A., Ward, A., Wilder, C., Neunert, C., Kutlar, A. & Pace, B. S., Feb 1 2019, In : Experimental Hematology. 70, p. 85-96.e5Research output: Contribution to journal › Article
Fetal Hemoglobin
Globins
Sickle Cell Anemia
Gene Silencing
MicroRNAs
1
Citation
(Scopus)
A thalidomide–hydroxyurea hybrid increases HbF production in sickle cell mice and reduces the release of proinflammatory cytokines in cultured monocytes
Lanaro, C., Franco-Penteado, C. F., Silva, F. H., Fertrin, K. Y., dos Santos, J. L., Wade, M., Yerigenahally, S., de Melo, T. R., Chin, C. M., Kutlar, A., Meiler, S. E. & Costa, F. F., Feb 1 2018, In : Experimental Hematology. 58, p. 35-38 4 p.Research output: Contribution to journal › Article
Sickle Cell Anemia
Monocytes
Hydroxyurea
Cytokines
Thalidomide
3
Citations
(Scopus)
CB1R-mediated activation of caspase-3 causes epigenetic and neurobehavioral abnormalities in postnatal ethanol-exposed mice
Subbanna, S., Nagre, N. N., Shivakumar, M., Joshi, V., Psychoyos, D., Kutlar, A., Siddaramappa, U. N. & Basavarajappa, B. S., Feb 20 2018, In : Frontiers in Molecular Neuroscience. 11, 45.Research output: Contribution to journal › Article
Epigenomics
Caspase 3
Ethanol
Methyl-CpG-Binding Protein 2
Fetal Alcohol Spectrum Disorders
The missing middle of sickle therapeutics: Multi-agent therapy, targeting risk, using biomarkers
Hebbel, R. P., Elion, J. & Kutlar, A., Dec 1 2018, In : American Journal of Hematology. 93, 12, p. 1439-1443 5 p.Research output: Contribution to journal › Comment/debate
Biomarkers
Therapeutics